Tuesday, January 30, 2007 - 18:30

Innate Pharma SA announced today the commercial launch by its partner, Clinical Data Inc. (NASDAQ: CLDA) of PGxPredict:RITUXIMAB, a pharmacogenetic test that should help physicians to predict the likelihood of a given patient responding to rituximab  monotherapy in the treatment of follicular non-Hodgkin's lymphoma.

AttachmentSize
PR in english97.16 KB
CP en français32.68 KB